Measurement of circulatory unhydrolysed mycophenolate mofetil (MMF) to mycophenolic acid (MPA) with intravenous MMF in post liver transplant patients.

被引：0
|
作者：
Jain, Ashok
Mohanka, Ravi
Tai, Kwong
Orloff, Mark
Abt, Peter
Bozorgzadeh, Adel
机构：
[1] Univ Rochester, Med Ctr, Div Transplantat, Rochester, NY 14642 USA
[2] Univ Rochester, Med Ctr, Dept Biochem, Rochester, NY 14642 USA
来源：
LIVER TRANSPLANTATION | 2006年 / 12卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：C125 / C125
页数：1
相关论文
共 50 条
  • [41] Atypical presentation of late onset post transplant lymphoproliferative disorder (PTLD) in paediatric renal transplant recipients on Sirolimus and mycophenolate mofetil (MMF)
    Convery, M.
    Howatson, A.
    Waller, S.
    Maxwell, H.
    Beattie, J.
    [J]. PEDIATRIC NEPHROLOGY, 2008, 23 (09) : 1690 - 1690
  • [42] Introduction of mycophenolate mofetil (MMF) and ciclosporine (CSA) withdrawal in heart transplant patients with progressive deteriorating renal function
    Dureau, G
    Obadia, JF
    Chuzel, M
    Boissonnat, P
    [J]. TRANSPLANTATION, 1999, 67 (07) : S24 - S24
  • [43] Enteric-Coated Mycophenolate Sodium (EC-MPS) Versus Mycophenolate Mofetil (MMF) in African American (AA) Renal Transplant Recipients from the Mycophenolic Acid Observational Renal Transplant (MORE) Registry
    Narayanan, M.
    Pankewycz, O.
    El-Ghoroury, M.
    Wiland, A.
    Mccague, K.
    Daller, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 316 - 317
  • [44] Pharmacokinetic basis of efficient and safe use of low mycophenolate mofetil (MMF,1g/day) in combination with Tacrolimus in kidney transplant patients.
    Mourad, ML
    Malaise, J
    Chaib-Eddour, D
    Scheppers, R
    De Koenig, J
    Wallemacq, P
    Squifflet, JP
    [J]. TRANSPLANTATION, 2000, 69 (08) : S161 - S161
  • [45] A Prospective Study To Investigate Mycophenolic Acid (MPA) Exposure Through Area Under The Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) or Enteric Coated Mycophenolate Sodium (EC-MPS)
    Pacheco, L.
    Vizioli, N.
    Dal Pra, R.
    Cardoso, B.
    Kist, R.
    Garcia, V.
    Keitel, E.
    [J]. TRANSPLANTATION, 2014, 98 : 258 - 258
  • [46] Early Outcome Analysis of the Mycophenolic Acid Observational Renal Transplant (MORE) Registry: Comparisons of Enteric-Coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Patients with Diabetes Mellitus (DM) Prior to Transplant.
    Shihab, F.
    Chan, L.
    Narayanan, M.
    Moritz, M.
    Wiland, A.
    McCague, K.
    Doria, C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 319 - 319
  • [47] Severe anemia with Sofosbuvir based therapy for Hepatitis C (HCV) recurrence post Liver transplantation on mycophenolate mofetil (MMF)
    Elsiesy, Hussien
    Ajlan, Aziza A.
    Aljedai, Ahmed
    Alarieh, Rania
    Al-Hamoudi, Waleed K.
    Alkortas, Delal
    Al Sebayel, Mohammed
    Broering, Dieter C.
    Abaalkhail, Faisal A.
    [J]. HEPATOLOGY, 2014, 60 : 702A - 703A
  • [48] A Prospective Study To Investigate Mycophenolic Acid (MPA) Exposure Through Area Under The Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) or Enteric Coated Mycophenolate Sodium (EC-MPS)
    Pacheco, L.
    Vizioli, N.
    Dal Pra, R.
    Cardoso, B.
    Kist, R.
    Garcia, V.
    Keitel, E.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 258 - 258
  • [49] Mycophenolate mofetil (MMF) monotherapy improves renal dysfunction in orthotopic liver transplant (OLT) recipients without increased risk of rejection
    Raimondo, ML
    Dagher, L
    Papatheodoridis, G
    Gunsar, F
    Turchi, V
    Rolles, K
    Davidson, B
    Patch, D
    Burroughs, A
    [J]. JOURNAL OF HEPATOLOGY, 2002, 36 : 193 - 193
  • [50] Optimal dosing of mycophenolate mofetil (MMF) is necessary to delay hepatitis C recurrence (HEP CR) in liver transplant recipients.
    Fasola, CG
    Netto, GJ
    Christensen, LL
    Sanchez, EQ
    Molmenti, EM
    Gonwa, TA
    Goldstein, RM
    Levy, MF
    Klintmalm, GB
    [J]. HEPATOLOGY, 2001, 34 (04) : 639A - 639A
12345